Education
About Us
Working with TipRanks
Follow Us
Apogee Therapeutics (APGE)
NASDAQ:APGE
Dupilumab, Apg777, Apg990
Atopic Dermatitis
Phase I
Recruiting
An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic Dermatitis
Jun 11, 2025
―
Apg777
Atopic Dermatitis
Phase II
Recruiting
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
May 26, 2025
―
Apg777
Asthma
Phase I
Active Not Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Immunogenicity of APG777 in Adults With Asthma
Mar 27, 2025
―
Apg777
Atopic Dermatitis
Phase II
Recruiting
A Study Evaluating APG777 in Atopic Dermatitis
Apr 29, 2024
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Apogee Therapeutics (APGE) have in its pipeline
APGE is currently developing the following drugs: Dupilumab, Apg777, Apg990, Apg777, Apg777. These drug candidates are in various stages of clinical development as the company works toward FDA approval.